Annual EBITDA
-$15.75 M
-$2.56 M-19.44%
31 March 2024
Summary:
OKYO Pharma Limited annual earnings before interest, taxes, depreciation & amortization is currently -$15.75 million, with the most recent change of -$2.56 million (-19.44%) on 31 March 2024. During the last 3 years, it has fallen by -$12.38 million (-368.03%). OKYO annual EBITDA is now -176.45% below its all-time high of $20.60 million, reached on 31 March 2010.OKYO EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OKYO EBITDA Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -19.4% | - | - |
| 3 y3 years | -368.0% | - | - |
| 5 y5 years | -221.2% | - | - |
OKYO EBITDA High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -368.0% | at low | ||||
| 5 y | 5 years | -876.1% | at low | ||||
| alltime | all time | -176.4% | at low |
OKYO Pharma Limited EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2024 | -$15.75 M(+19.4%) | - | - |
| Mar 2023 | -$13.18 M(+112.1%) | - | - |
| Mar 2022 | -$6.22 M(+84.7%) | - | - |
| Mar 2021 | -$3.36 M(+108.5%) | - | - |
| Mar 2020 | -$1.61 M(-67.1%) | - | - |
| Mar 2019 | -$4.90 M(+370.2%) | - | - |
| Mar 2018 | -$1.04 M(+187.0%) | - | - |
| Mar 2017 | -$363.30 K(-66.9%) | - | - |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | -$1.10 M(-37.3%) | - | - |
| Mar 2015 | -$1.75 M(-87.3%) | - | - |
| Mar 2014 | -$13.82 M(+193.4%) | - | - |
| Mar 2013 | -$4.71 M(-12.7%) | - | - |
| Mar 2012 | -$5.39 M(+216.7%) | - | - |
| Mar 2011 | -$1.70 M(-108.3%) | - | - |
| Mar 2010 | $20.60 M(+36.4%) | - | - |
| Mar 2009 | $15.10 M(-577.0%) | - | - |
| Mar 2008 | -$3.17 M | - | - |
FAQ
- What is OKYO Pharma Limited annual earnings before interest, taxes, depreciation & amortization?
- What is the all time high annual EBITDA for OKYO Pharma Limited?
- What is OKYO Pharma Limited annual EBITDA year-on-year change?
What is OKYO Pharma Limited annual earnings before interest, taxes, depreciation & amortization?
The current annual EBITDA of OKYO is -$15.75 M
What is the all time high annual EBITDA for OKYO Pharma Limited?
OKYO Pharma Limited all-time high annual earnings before interest, taxes, depreciation & amortization is $20.60 M
What is OKYO Pharma Limited annual EBITDA year-on-year change?
Over the past year, OKYO annual earnings before interest, taxes, depreciation & amortization has changed by -$2.56 M (-19.44%)